Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Evidence",
"id" : "397481",
"meta" : {
"versionId" : "6",
"lastUpdated" : "2025-09-13T18:19:34.404Z"
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Title: </b>Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan</p><p><b>Variable in role of population: </b>the study group</p><p><b>Variable in role of exposure: </b>GroupAssignment: Quadpill vs. Candesartan</p><p><b>Variable in role of outcome: </b>Medication Adherence at 12 weeks</p><p><b>Statistic: </b>odds ratio (coded as: STATO:0000182 from https://fevir.net/sevco) 0.37</p></div>"
},
"url" : "https://fevir.net/resources/Evidence/397481",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net/FOI",
"value" : "397481",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"name" : "Evidence_for_Results_for_Medication_Adherence_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan",
"title" : "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan",
"citeAs" : "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 397481. Revised 2025-09-13. Available at: https://fevir.net/resources/Evidence/397481. Computable resource at: https://fevir.net/resources/Evidence/397481#json.",
"status" : "active",
"author" : [
{
"name" : "Brian S. Alper, MD, MSPH"
}
],
"publisher" : "Computable Publishing LLC",
"contact" : [
{
"telecom" : [
{
"system" : "email",
"value" : "support@computablepublishing.com"
}
]
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"relatesTo" : [
{
"type" : "part-of",
"targetReference" : {
🔗 "reference" : "Composition/375280",
"type" : "Composition",
"display" : "Outcome Measure Report for QUARTET USA Trial"
}
}
],
"description" : "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"variableDefinition" : [
{
"variableRole" : "population",
"observed" : {
"display" : "the study group"
}
},
{
"variableRole" : "exposure",
"observed" : {
🔗 "reference" : "EvidenceVariable/375183",
"type" : "EvidenceVariable",
"display" : "GroupAssignment: Quadpill vs. Candesartan"
}
},
{
"variableRole" : "outcome",
"observed" : {
🔗 "reference" : "EvidenceVariable/375201",
"type" : "EvidenceVariable",
"display" : "Medication Adherence at 12 weeks"
}
}
],
"statistic" : [
{
"statisticType" : {
"coding" : [
{
"system" : "https://fevir.net/sevco",
"code" : "STATO:0000182",
"display" : "odds ratio"
}
]
},
"quantity" : {
"value" : 0.37
},
"sampleSize" : {
"numberOfParticipants" : 62,
"knownDataCount" : 53
},
"attributeEstimate" : [
{
"type" : {
"coding" : [
{
"system" : "https://fevir.net/sevco",
"code" : "STATO:0000196",
"display" : "confidence interval"
}
]
},
"level" : 0.95,
"range" : {
"low" : {
"value" : 0.19
},
"high" : {
"value" : 2.08
}
}
},
{
"type" : {
"coding" : [
{
"system" : "https://fevir.net/sevco",
"code" : "STATO:0000700",
"display" : "p-value"
}
]
},
"quantity" : {
"value" : 0.444
}
}
]
}
]
}